India will continue using hydroxychloroquine (HCQ) as a preventative measure against COVID-19, after the Indian Council of Medical Research (ICMR) declared on Tuesday that the drug was found to be very effective with minimal side effects for prophylaxis.
The ICMR's decision was based on three studies they conducted, which resulted in a Friday advisory to expand the drug's use, according to ThePrint.
Speaking at a Tuesday press conference, ICMR Director General Dr. Balram Bhargava said "COVID-19 is an evolving field. We don’t know which medicines are working and which are not. There are lots of drugs that have been repurposed for use in COVID whether prophylaxis or as treatment. HCQ is a very old anti-malarial drug that was being widely used and it continues to be widely used. It is safer."
"We did some invitro study in labs and found that it has antiviral properties. This drug became suddenly popular when the American government also started using it and they got-fast track approval or emergency use authorisation. We also thought that it may be a useful drug for prevention of COVID," he added.
More
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
2 comments:
But Orange Man still bad.
All doctors are prescribing it now. It's working all the time unless someone isn't prescribed it soon enough.
Post a Comment